STOCK TITAN

Veeva Systems Inc - VEEV STOCK NEWS

Welcome to our dedicated news page for Veeva Systems (Ticker: VEEV), a resource for investors and traders seeking the latest updates and insights on Veeva Systems.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Veeva Systems's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Veeva Systems's position in the market.

Rhea-AI Summary
SK Life Science, Inc. (NYSE: VEEV) adopts Veeva Vault Validation Management to streamline and accelerate their validation process, improving efficiency, data integrity, and audit readiness. The company aims to modernize validation for greater efficiency and speed, driving greater compliance and traceability across all systems.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.33%
Tags
none
-
Rhea-AI Summary
Veeva Systems (NYSE: VEEV) CEO to Present at 42nd Annual J.P. Morgan Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.61%
Tags
conferences
-
Rhea-AI Summary
Recipharm (NYSE: RECI) to Standardize Quality Operations with Veeva Vault QMS, QualityDocs, and Training
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.74%
Tags
none
Rhea-AI Summary
Veeva Systems Inc. (NYSE: VEEV) reported total revenues of $616.5M, up 12% year over year, with subscription services revenues of $494.9M, also up 12% year over year. Operating income was $128.5M, a 6% increase, and non-GAAP net income was $218.7M, a 19% increase. The company announced significant commercial and data platform innovations, positioning itself for profitable growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.05%
Tags
earnings
-
Rhea-AI Summary
Veeva Systems (VEEV) announced that GSK will be one of the first top biopharma companies to migrate to Veeva Vault CRM, aiming to positively impact 2.5 billion people by the end of 2030. The adoption of the next generation CRM for life sciences will enable GSK to interact with customers based on their needs and in ways that work best for them, leading to more effective healthcare professional engagement. GSK's senior vice president of commercial and digital technology, Kieron Scrutton, emphasized the importance of data and technology in achieving GSK's goals, stating that moving to Vault CRM is a clear next step for the company. Veeva's president and chief operating officer, Tom Schwenger, highlighted the trusted partnership between GSK and Veeva, expressing confidence in GSK's forward-thinking approach to customer relationships by taking full advantage of Vault CRM and future innovations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.83%
Tags
none
-
Rhea-AI Summary
Veeva Systems (VEEV) partners with Bayer to establish a connected software and data foundation for the future with next-generation life sciences CRM and harmonized customer data. Bayer will be among the first top 20 biopharmas to move to Veeva Vault CRM worldwide, standardizing global customer data with Veeva OpenData. This move will allow Bayer to leverage AI-driven engagement across channels and geographies, driving more precise and effective customer engagement in every region and therapeutic area.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.83%
Tags
none
Rhea-AI Summary
Veeva Systems (NYSE: VEEV) to announce its third-quarter financial results for fiscal 2024 on December 6, 2023, after market close. The company will host a conference call and webcast to discuss the results and will post prepared remarks on its investor relations website. A webcast replay will be available after the live event.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.83%
Tags
earnings
-
Rhea-AI Summary
Veeva MedTech - Growing Regulatory Complexity Driving Need for a Single Source of Regulatory Information
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.92%
Tags
none
-
Rhea-AI Summary
Veeva Systems (NYSE: VEEV) reveals that compliant chat channels increase HCP engagement by over 30%, with rapid response times of less than five minutes. GSK's global product director emphasizes the importance of responsiveness and value-added communication.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.18%
Tags
none
Rhea-AI Summary
Veeva Systems to host virtual Investor Day on November 9, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.07%
Tags
conferences
Veeva Systems Inc

NYSE:VEEV

VEEV Rankings

VEEV Stock Data

37.65B
147.84M
8.19%
84.21%
1.3%
Software Publishers
Information
Link
United States
Pleasanton

About VEEV

veeva systems inc. is a leader in cloud-based software for the global life sciences industry. committed to innovation, product excellence, and customer success, veeva has more than 300 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. veeva is headquartered in the san francisco bay area, with offices in europe, asia, and latin america. for more information, visit www.veeva.com.